Congo - Brazzaville travel health

Overview

Plan for vaccine checks and mosquito protection. The Republic of the Congo (Congo–Brazzaville) is a yellow‑fever–endemic country that also has year‑round malaria transmission; healthcare outside Brazzaville and Pointe‑Noire may be limited. Recent cholera activity has affected riverine districts. Carry documentation for vaccines, a full malaria prescription, insect repellent, and travel/medical‑evacuation insurance.

Entry requirements — yellow fever

The government of the Republic of the Congo requires proof of yellow fever vaccination for incoming travellers; many travel authorities advise vaccination for visitors. National and international sources differ slightly on age thresholds (some documents use ≥9 months, others older older references cite 1 year) and on how requirements apply to travellers arriving from or transiting through other risk countries — so confirm with the embassy or carrier before travel. U.S. Department of State: Republic of Congo travel advisory, U.S. CDC: Republic of the Congo, WHO International Travel & Health (country list).

Routine and recommended vaccinations

Make sure routine vaccines are up to date (MMR, diphtheria‑tetanus‑pertussis, polio, influenza, etc.). For most travellers the following are widely recommended: hepatitis A, typhoid (oral or injectable), and hepatitis B when there is sexual, medical or occupational exposure risk. Rabies pre‑exposure vaccination should be considered for long stays, remote travel, or repeated animal exposure; prompt post‑exposure treatment is critical but may be hard to access outside major cities. Yellow fever vaccine is recommended for people going to risk areas and is required by national entry rules as noted above. Consult a travel‑medicine provider ideally 4–6 weeks before departure to complete multi‑dose series if needed. U.S. CDC: vaccines & medicines for Congo, Embassy of the Republic of Congo: before you go.

Administrative notes about certificates

A valid International Certificate of Vaccination (yellow card) is the standard proof if required; carry the original. Some national authorities or carriers may additionally ask for passport validity of six months on arrival — check visa and entry rules with the embassy or your airline. U.S. Department of State: entry & vaccination notes, Embassy of the Republic of Congo: travel documents.

Other health risks

Non‑vaccine risks that commonly affect travellers include mosquito‑borne infections, water‑ and food‑borne illness, and animal exposures; the level of risk varies by location, season and activity.

Malaria

Malaria transmission occurs throughout the country year‑round (predominantly Plasmodium falciparum). The CDC and WHO recommend that travellers to the Republic of the Congo take prescription antimalarial prophylaxis; choose a regimen in discussion with your clinician (options include atovaquone‑proguanil, doxycycline, mefloquine or tafenoquine where appropriate). Strict bite‑avoidance (DEET or picaridin repellents, permethrin‑treated clothing, bed nets) is essential. U.S. CDC: malaria advice for Congo, WHO regional malaria country profile: Republic of the Congo.

Cholera and other diarrhoeal diseases

Outbreaks of cholera were declared in 2025 and recent reports describe cases concentrated in riverine and Brazzaville districts; cholera is transmitted by contaminated water and food. Travellers should follow safe‑food and safe‑water precautions and seek immediate care for severe watery diarrhoea. Oral cholera vaccine may be considered for people who will be working or living in areas with active cholera transmission; check latest local status before travel. U.S. CDC: localized cholera activity, WHO: outbreak situation report (2025), United Nations in Congo: emergency response.

Vector‑borne viruses (dengue, chikungunya, yellow fever)

Dengue and chikungunya occur in the region; prevent mosquito bites day and night. Yellow fever is endemic — vaccination protects individuals and meets entry rules described above. U.S. CDC: dengue, chikungunya, yellow fever, WHO: yellow fever & travel guidance.

Rabies and animal exposures

Dogs with rabies are commonly reported. Pre‑exposure rabies vaccination should be considered for travellers who will be in remote areas, doing animal‑handling work, or who may have delayed access to post‑exposure treatment. If bitten or scratched, wash the wound immediately and seek medical care; post‑exposure immunoglobulin and vaccine may be scarce outside major urban hospitals. U.S. CDC: rabies.

Freshwater risks and other parasites

Schistosomiasis is present — avoid swimming, wading or drinking freshwater in rivers, lakes and slow streams. Tsetse‑fly areas pose a risk of African trypanosomiasis (sleeping sickness) in selected rural locations. Practice insect avoidance and seek guidance if you will work or stay in forested or riverine zones. U.S. CDC: schistosomiasis & trypanosomiasis.

Healthcare and medicine access

Advanced medical and emergency evacuation resources are limited outside Brazzaville and Pointe‑Noire. Fill prescriptions before departure, bring a first‑aid kit, and consider travel medical and evacuation insurance. Have printed contact details for local hospitals and your embassy. U.S. Department of State: health & medical care, U.S. CDC: healthcare access advice.

Current health alerts

Only locally supported, time‑limited developments are listed here.

Cholera outbreak (2025–2026) — riverine and Brazzaville districts

A cholera outbreak was officially declared in late June–July 2025 with cases concentrated in Brazzaville (including Mbamou Island / Talangai districts) and riverine departments; international and UN reports document cases, deaths and targeted oral‑vaccine distributions through 2025 and into early 2026. Travellers to affected areas should follow strict food‑and‑water precautions and seek care promptly for severe diarrhoea; consider cholera vaccine if you will be living or working in an area with active transmission. Check local health notices before travel for current geographic scope. WHO Weekly Outbreak Bulletin (2025 report), United Nations in Congo: CHOLERA response, U.S. CDC: localized cholera activity.

Before you travel

Get a travel consultation 4–6 weeks before departure so vaccines and any multi‑dose schedules can be completed; sooner if you need yellow fever vaccination for entry. Pack insect repellent (DEET or picaridin), a bed net or permethrin‑treated clothing for rural stays, a full malaria prescription, a personal first‑aid kit, and copies of vaccination and insurance documents.

Practical preparations

Check entry and visa rules with the Republic of the Congo embassy; confirm yellow fever certificate requirements with your airline and the embassy (requirements and age thresholds vary in source documents). Buy travel and medical‑evacuation insurance, bring medicines from home (avoid sourcing critical drugs locally), and make contingency plans for limited services outside main cities. Embassy of the Republic of Congo: before you go, U.S. Department of State: travel guidance, U.S. CDC: traveller checklist.

This information summarizes published public‑health guidance. A travel‑health professional can advise on your itinerary, medical history and vaccination needs.

Recent reports

Cholera — Gamboma district (Nkéni‑Alima department), Republic of the Congo

Local health teams detected and laboratory‑confirmed cholera cases in Gamboma in early October 2026; rapid diagnostic tests were positive and samples were confirmed at a Brazzaville laboratory, and at least one death was reported among the household cluster described in the field report. UNICEF field report (5 Oct 2026). The UNICEF account says immediate treatment and isolation measures were put in place, that health teams used rapid tests and PPE, and that no recent additional cases were detected in Gamboma at the time of the report but that risk remains in neighbouring areas. UNICEF (5 Oct 2026). Why it matters to travellers: cholera is transmitted by contaminated food or water; travellers visiting rural or riverine communities where safe water and sanitation are limited could be exposed. Public sources note that for most travellers the risk is low if they have access to safe food and water, and that cholera vaccination is usually reserved for people at higher occupational or exposure risk (for example, humanitarian workers) — see practical guidance on prevention and the limited role of routine vaccination. Australian Immunisation Handbook — Cholera (updated 30 Sep 2026).

Ebola (Bundibugyo) — ongoing outbreak in neighbouring Democratic Republic of the Congo; cross‑border risk

An expansive outbreak of Ebola disease caused by Bundibugyo virus continues in the Democratic Republic of the Congo (DRC); WHO reported thousands of confirmed cases and a high number of deaths in its 26 August 2026 Disease Outbreak News and advised that the risk to countries sharing land borders with the DRC is high because of population mobility. WHO Disease Outbreak News (26 Aug 2026). WHO also reports that entry and exit screening and surveillance measures are in place at airports, ports and official land border crossings in the affected area and stresses the importance of cross‑border collaboration and preparedness. WHO (26 Aug 2026). As of the WHO report, no confirmed Bundibugyo cases were reported from the Republic of the Congo; however, the geographic expansion in the DRC and cross‑border movements have prompted heightened surveillance across the region. WHO. Several neighbouring and regional authorities have publicly described active traveller screening and contact‑tracing measures after imported cases were detected elsewhere in the region (example: Kenya’s October 2026 screening and tracing following an imported case). Pulse Kenya (6 Oct 2026). Why it matters to travellers: travellers who transit to or from the DRC or who plan travel to border areas should expect enhanced port‑health checks in some countries, should follow local health authority instructions, and should seek medical advice promptly for fever or other compatible symptoms; WHO currently advises against general travel restrictions but recommends strengthened surveillance and cross‑border preparedness. WHO (26 Aug 2026).

Official entry health requirement to note

The Republic of the Congo continues to require proof of yellow fever vaccination for travellers; national and foreign government travel pages confirm that a valid International Certificate of Vaccination (yellow card) may be checked at entry. Government of Canada travel advice for Congo‑Brazzaville (updated Sep 2026). Travellers should carry their original certificate and verify any additional documentary requirements with the destination’s diplomatic mission before travel.

This summary is a dated snapshot of outbreak reporting and official measures based on sources checked on 27 October 2026. Conditions can change rapidly; travellers should check the country health guide, official ministry of health announcements, and trusted international public‑health sources (WHO, national public health institutes) for updates before departure.